New study investigates chewing and swallowing problems in scleroderma patients

NCT ID NCT07182981

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how scleroderma affects chewing and swallowing in both children and adults. Researchers will use questionnaires and physical tests to measure these functions and understand the overall well-being of participants. The goal is to find better tools for assessing these issues and improve disease management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could identify better ways to assess chewing and swallowing problems in people with scleroderma, leading to improved care.

What could go wrong

This is an observational study with only 50 participants, so findings may not apply to everyone with scleroderma. It does not test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCLERODERMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse scleroderma Juvenile-onset scleroderma localized scleroderma scleroderma systemic sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hacettepe University

    RECRUITING

    Çankaya, Ankara, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••